Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

About this grant

Through this Notice of Funding Opportunity (NOFO), NCI solicits applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC), to conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify patients who are at high risk of progression to cancer. The PCDC will continue to address one of the four research priorities identified in the NCI's 2014 Scienti Grant Number: PAR-26-120. Expected awards: 10.

Eligibility requirements

All of the following criteria must be met:

• Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
• Grant Number: PAR-26-120

What the funding covers

• See official listing for award details
• Expected Number of Awards: 10

How to apply

1. 1Applications must be submitted through grants.gov
2. 2Grant Number: PAR-26-120
3. 3Posted: 2026-02-11

Application tips